VIDEO: Advice varies for chemoprevention, genetic testing in invasive breast cancer
MIAMI – The message from major trials evaluating tamoxifen, raloxifene, and aromatase inhibitors for chemoprevention of invasive breast cancer got clearer with data from extended follow-up coming in....
Source: Family Practice News - Category: Primary Care Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Evista | Family Practices | Genetics | Primary Care | Tamoxifen